Administration of Enfortumab Vedotin after Immune-Checkpoint Inhibitor and the Prognosis in Japanese Metastatic Urothelial Carcinoma: A Large Database Study on Enfortumab Vedotin in Metastatic Urothelial Carcinoma

Kawahara, T; Hasizume, A; Uemura, K; Yamaguchi, K; Ito, H; Takeshima, T; Hasumi, H; Teranishi, J; Ousaka, K; Makiyama, K; Uemura, H

Kawahara, T (通讯作者)，Yokohama City Univ Med Ctr, Dept Urol & Renal Transplantat, 4-57 Urafune Cho,Minami Ku, Yokohama 2320024, Japan.;Kawahara, T (通讯作者)，Yokohama City Univ, Grad Sch Med, Dept Urol, Yokohama 2360027, Japan.

CANCERS, 2023; 15 (17):

Abstract

Simple Summary Enfortumab vedotin, a targeted therapy for advanced urothelial carcinoma, has shown efficacy, especially in those treated with platinum......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索